1.   All of this has to happen before a drug can be licensed for use in this country.

2.   Armed with successful results, the Israeli researchers licensed the drug to Teva.

3.   Bayer is a German company, but its drug was licensed in Europe by the British authorities while neighboring countries essentially adopted its decision.

4.   Big drug companies have relatively few major breakthroughs coming from their own labs, so they are licensing more drugs from biotechnology companies.

5.   Europe does have a centralized regulatory agency, the European Agency for the Evaluation of Medical Products, which licenses all drugs produced through genetic engineering.

6.   In Latin America, Eisai has licensed the drug to American Home Products Corp., a U.S. drugmaker.

7.   In the past, the company has licensed drugs to marketing partners, receiving royalties on sales.

8.   In the past, it has licensed drugs to marketing partners and received royalty revenues on sales.

9.   Instead, many of them are licensing their drugs to ICN for sale in Eastern Europe and Russia.

10.   John Maraganore, senior vice president of strategic product development, said several big pharmaceutical and biotechnology companies were bidding to license the drug.